controluser

ExCEEd Orphan Announces Extension of an Exclusive Distribution Agreement with Mirum Pharmaceuticals for Marketing and Distribution of LIVMARLI™ (maralixibat) to Additional CEE Countries

December 13, 2023

ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o., …

November 16, 2023

ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o., …

January 19, 2023

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

January 11, 2023

ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o., …

November 18, 2022

Stockholm, Sweden, 17 Nov 2022 – Neobiomics AB and ExCEEd Orphan s.r.o. have …

November 1, 2022

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

August 1, 2022

Jerusalem, Israel and Prague, Czech Republic, August 1st, 2022. Rafa Laboratories LTD. (“Rafa”) …

July 15, 2022

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

July 13, 2022

Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to …